Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

Skin RAGE levels are linked to inflammation and cell death.

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

EGF and EGFR are essential for goat fetal skin development.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Scientists found a specific group of itch-sensing nerve cells in mice important for feeling itch but not for sensing heat or touch.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

Edar signaling is crucial for proper hair follicle development and function.

PDGF and its receptors are crucial for stem cell growth and function.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

Meis2 is essential for touch sensation and nerve function in mice.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

Understanding EGFR roles could lead to new hair loss treatments.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

The EDA pathway plays a key role in bone development by interacting with other signaling pathways.

PDCD4 is important for controlling skin cell growth and healing.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

AHR ligands could treat inflammatory skin diseases.